Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christopher Zeruto"'
Autor:
Clara J K Lam, Murray Krahn, Ning Liu, Jeffrey S Hoch, Christopher Zeruto, Joan L. Warren, Claire de Oliveira, Angela B. Mariotto, Michael J. Barrett, Diarmuid Coughlan, Kelvin K. W. Chan, Karen E. Bremner, K. Robin Yabroff
Publikováno v:
JCO Oncol Pract
PURPOSE: End-of-life (EOL) cancer care is costly, with challenges regarding intensity and place of care. We described EOL care and costs for patients with colorectal cancer (CRC) in the United States and the province of Ontario, Canada, to inform bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb4d423e54bcf43d84f6ea0d61528630
https://doi.org/10.1200/jop.19.00061
https://doi.org/10.1200/jop.19.00061
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: The prevalence of cancer survivorship is increasing. In this study, we provide contemporary population–based estimates and projections of the overall and site-specific cancer-attributable medical care costs in the United States. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63de92bede59b2626ae793be9e3045ae
https://pubmed.ncbi.nlm.nih.gov/32522832
https://pubmed.ncbi.nlm.nih.gov/32522832
Autor:
KR Yabroff, Christopher Zeruto, Lirong Zhao, Michael J. Barrett, Joan L. Warren, Angela B. Mariotto, Diarmuid Coughlan
Publikováno v:
J Natl Cancer Inst Monogr
Medical care costing studies have excluded patients with a prior cancer history. This study aims to update methods for estimating medical care costs attributable to cancer and to evaluate the effect of a prior history of cancer on costs for colorecta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d51a25bfc0c2276c8682b06a32f6b145
https://pubmed.ncbi.nlm.nih.gov/32412066
https://pubmed.ncbi.nlm.nih.gov/32412066
Autor:
Christopher Zeruto, K. Robin Yabroff, Joan L. Warren, Cathy J. Bradley, Neetu Chawla, Elizabeth B. Lamont
Publikováno v:
Medical Care. 54:490-497
Background:Little is known about the use and costs of antineoplastic regimens for elderly patients with metastatic colorectal cancer (mCRC). We report population-based trends over a 10-year period in the treatment, survival, and costs in mCRC patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24a8a295ed7802e0fa5229078ef91207
https://doi.org/10.1097/mlr.0000000000000510
https://doi.org/10.1097/mlr.0000000000000510
Autor:
Angela B. Mariotto, Christopher Zeruto, Joan L. Warren, Quyen Tran, Cathy J. Bradley, K. Robin Yabroff
Purpose Multiple agents for advanced non–small-cell lung cancer (NSCLC) have been approved in the past decade, but little is known about their use and associated spending and survival. Methods We used SEER-Medicare data for elderly patients with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8afde15dbe77e754653e17609bc4cb5a
https://europepmc.org/articles/PMC5455316/
https://europepmc.org/articles/PMC5455316/
Autor:
Neetu Chawla, Cathy J. Bradley, Elizabeth B. Lamont, Joan L. Warren, Christopher Zeruto, K. Robin Yabroff
Little is known about the use and costs of antineoplastic regimens for elderly patients with metastatic colorectal cancer (mCRC). We report population-based trends over a 10-year period in the treatment, survival, and costs in mCRC patients, stratifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8fdb6f28d67cb39aef24f1023c83a5e
https://europepmc.org/articles/PMC5145731/
https://europepmc.org/articles/PMC5145731/
Publikováno v:
Melanoma Research. 21:547-554
We examined trends in the treatment and survival in a population-based sample of white patients diagnosed with local-stage and regional-stage cutaneous melanoma in 1995, 1996, or 2001, treated in communities across the USA with vital status follow-up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28704942982bb28e576ce3949d64f625
https://doi.org/10.1097/cmr.0b013e32834b58e4
https://doi.org/10.1097/cmr.0b013e32834b58e4
Autor:
Emily Dowling, Dennis W. Buckman, K. Robin Yabroff, Angela B. Mariotto, Christopher Zeruto, Timothy S. McNeel
Publikováno v:
Cancer. 116:3712-3721
BACKGROUND: The number of adult survivors of childhood cancer in the United States is increasing because of effective treatments and improved survival. The purpose of this study was to use a national, population-based sample to estimate the burden of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8451a4f6c6eebb2ec11fa5acdf627d4a
https://doi.org/10.1002/cncr.25141
https://doi.org/10.1002/cncr.25141
Publikováno v:
BMC Cancer
Background Physician recommendations for cancer screening and prevention are associated with patient compliance. However, time constraints may limit physicians’ ability to provide all recommended preventive services, especially with increasing dema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaca2581ab49608671100bbe268f7229
https://doi.org/10.1186/1471-2407-14-233
https://doi.org/10.1186/1471-2407-14-233
Publikováno v:
Neuro-oncology. 14(3)
Standard treatment for glioblastoma multiforme (GBM) changed in 2005 when addition of temozolomide (TMZ) to maximal surgical resection followed by radiation therapy (RT) was shown to prolong survival in a clinical trial. In this study, we assessed tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4973e92a12da137ea1ee813e340fa81
https://pubmed.ncbi.nlm.nih.gov/22241797
https://pubmed.ncbi.nlm.nih.gov/22241797